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Endothelin-3The enteric nervous system (ENS), the intrinsic innervation of the gastrointestinal tract, consists of numerous
types of neurons, and glial cells, that are distributed in two intramuscular plexuses that extend along the en-
tire length of the gut and control co-ordinated smooth muscle contractile activity and other gut functions. All
enteric neurons and glia are derived from neural crest cells (NCC). Vagal (hindbrain) level NCC provide the
majority of enteric precursors along the entire length of the gut, while a lesser contribution, that is restricted
to the hindgut, arises from the sacral region of the neuraxis. After leaving the dorsal neural tube NCC undergo
extensive migration, proliferation, survival and differentiation in order to form a functional ENS. This article
reviews the molecular mechanisms underlying these key developmental processes and highlights the major
groups of molecules that affect enteric NCC proliferation and survival (Ret/Gdnf and EdnrB/Et-3 pathways,
Sox10 and Phox2b transcription factors), cell migration (Ret and EdnrB signalling, semaphorin 3A, cell adhe-
sion molecules, Rho GTPases), and the development of enteric neuronal subtypes and morphologies (Mash1,
Gdnf/neurturin, BMPs, Hand2, retinoic acid). Finally, looking to the future, we discuss the need to translate
the wealth of data gleaned from animal studies to the clinical area and thus better understand, and develop
treatments for, congenital human diseases affecting the ENS.
© 2012 Elsevier Inc. All rights reserved.The enteric nervous system
The enteric nervous system (ENS) is the largest and most complex
division of the peripheral and autonomic nervous systems (PNS and
ANS) in vertebrates. It contains numerous different types of neurons
comparable in number to that of the spinal cord and an array of neu-
rotransmitters and neuromodulators similar to those found in the
central nervous system (CNS). The ENS is organised into an intercon-
nected network of neurons and glial cells that are grouped into gang-
lia located in two major plexuses: the myenteric (Auerbach's) plexus
and the submucosal (Meissner's) plexus. ENS components form an
integrated circuitry that controls motility of the intestine, exchange
of ﬂuids across the mucosal surface, blood ﬂow and secretion of gut
hormones. Although the gut also receives extrinsic parasympathetic
and sympathetic innervation, the intrinsic neuronal circuits of the
ENS are able to generate reﬂex gut contractile activity independent
from any CNS intervention, setting the ENS apart from other compo-
nents of the ANS (Furness, 2006).Pre-enteric neural crest cells
The neural crest origin of the ENS was ﬁrst established by Yntema
andHammondwho showed that upon ablation of the vagal (hindbrain)rights reserved.region of the neural crest in avian embryos, enteric ganglia failed to
form along the length of the gastrointestinal tract (Yntema and
Hammond, 1954). These results were subsequently conﬁrmed and
extended by the use of isotopic and isochronic grafts of quail pre-
migratory neural crest into chick embryos (Le Douarin, 1973). Fate
mapping of the transplanted quail cells revealed a dual neural crest
origin for the ENS in which neural crest cells (NCC) emigrating from
the vagal region adjacent to somites 1–7 colonised the entire length of
the gut forming the majority of the ENS, whereas NCC arising caudal
to the 28th somite level (sacral NCC) contributed a smaller number of
cells to the post-umbilical gut only (Le Douarin and Teillet, 1973). Cell
lineage studies have subsequently revealed a similar origin for the
ENS in mammals (Anderson et al., 2006a; Durbec et al., 1996; Kapur,
2000; Serbedzija et al., 1991; Wang et al., 2011).
Vagal NCC emerge from the neural tube around embryonic day 8.5
(E8.5) in the mouse and migrate ventro-medially, reaching the fore-
gut at E9–E9.5 (Anderson et al., 2006a; Durbec et al., 1996). After
this stage NCC are termed enteric neural crest cells (ENCC), as they
contain ENS-restricted progenitor cells that migrate rostrocaudally
to colonise the entire length of the developing gut, a process that is
completed in approximately 5 days (by E14.5–E15.5). Sacral NCC de-
laminate from the neural tube at E9–E9.5 (Serbedzija et al., 1991), mi-
grate ventrally to form extrinsic pelvic ganglia adjacent to the
hindgut, then migrate from there into the gut to give rise to enteric
neurons and glia. In the chick, sacral NCC also initially form an extrin-
sic nerve, the nerve of Remark, where they reside for a number of
days before entering the hindgut (Burns and Douarin, 1998). Sacral
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their vagal counterparts (Burns and Douarin, 1998; Kapur, 2000).
However, they do not rely on vagal ENCC for hindgut colonisation to
occur as shown by the fact that sacral ENCC still migrate into the
gut, giving rise to enteric neurons and glia in the most distal regions
of the intestine even after ablation of the vagal neural crest
(Anderson et al., 2006a; Burns et al., 2000; Durbec et al., 1996;
Kapur, 2000).
Several studies have addressed cell autonomous properties of
pre-enteric vagal and sacral NCC in order to determine whether
these cells are pre-speciﬁed towards the ENS lineage, or whether
their fate depends on microenvironmental cues encountered along
migratory pathways. Transplantation of quail vagal and sacral NC
into new axial levels of chick embryos suggested that both of these
scenarios are valid to some extent. For example, heterotopically
grafted vagal and sacral NCC are able to migrate to sites characteristic
of their new axial level (Erickson and Goins, 2000; Le Douarin and
Teillet, 1974; Le Douarin et al., 1975); nevertheless, they seem to
retain some of their original properties and to be able, to a certain
extent, to reach the original target tissue (i.e. gut) (Barlow et al.,
2008; Burns et al., 2002; Le Douarin and Teillet, 1974; Smith et al.,
1977). In addition, a rapidly expanding number of markers have
been discovered that identify undifferentiated NCC prior to their
entry into the gut, which might point towards the existence of a
pre-enteric speciﬁed subset of NCC. Vagal and sacral NCC express
the transcription factor Sox10 before the onset of migration and
they maintain this expression until they reach the gut (Anderson
et al., 2006a; Southard-Smith et al., 1998). In avian embryos, pre-
migratory vagal NCC have also been shown to express the endothelin
receptor B (EDNRB) (Nataf et al., 1996). Shortly after emigration from
the neural tube, vagal NCC express the low-afﬁnity nerve growth
receptor p75 (Anderson et al., 2006a; Wilson et al., 2004) and,
while they are migrating in proximity to the dorsal aorta, they also
induce the expression of the transcriptional regulator Phox2b
(Pattyn et al., 1999) and the receptor tyrosine kinase RET (Anderson
et al., 2006a; Durbec et al., 1996; Pachnis et al., 1993). Interestingly,
recent ﬁndings have suggested a similar phenotypic proﬁle exists in
sacral NCC (Anderson et al., 2006a; Burns et al., 2002). However, it
is not clear whether all cells express all the markers or whether dif-
ferent phenotypic classes exist. An attempt to identify “pre-enteric”
NCC on the basis of concomitant or differential expression of markers
has been made by Anderson et al., who identiﬁed a possible
co-expression of Sox10+ p75+ in NCC located around the rostral
foregut, with a subpopulation of them also expressing Phox2b and
RET (Anderson et al., 2006a). Nevertheless, when cells enter the gut,
phenotypic restriction seems to be in place and undifferentiated
ENCC have a relatively deﬁned expression of molecules as outlined
below and as summarised in Fig. 1.Enteric neural crest cells
Vagal ENCC enter the embryonic mouse gut at E9.5 and undergo a
single rostrocaudal wave of migration to sequentially colonise all re-
gions of the developing gut (Kapur et al., 1992; Young et al., 1998a).
The mode of migration of ENCC along the mouse gut has been exam-
ined by time-lapse imaging (Druckenbrod and Epstein, 2005, 2007,
2009; Young et al., 2004). ENCC migrate through the gut predomi-
nantly in strands or chains of interconnected cells. Although the net
movement of the cell population has a clear rostrocaudal directional-
ity, individual cells at the migration wavefront have complex and
unpredictable trajectories (Young et al., 2004). While ENCC are mi-
grating through the gut mesenchyme, a subpopulation of cells starts
to differentiate into neurons and express pan-neuronal markers
(Baetge and Gershon, 1989; Young et al., 1999). Recent studies have
shown that many of these immature neurons are also migratingcaudally, although at a lower speed and for limited distances com-
pared to undifferentiated vagal ENCC (Hao et al., 2009).
A secondary wave of migration occurs when a subset of ENCC,
which had migrated initially through the outer half of the mesen-
chyme (the presumptive myenteric plexus), moves centripetally to
colonise the submucosal region and subsequently forms the submu-
cosal plexus (Jiang et al., 2003). However, in avian embryos, the con-
verse occurs; ENCC ﬁrst migrate within the submucosa then migrate
outwards to contribute to the myenteric plexus (Burns and Douarin,
1998).
During gut colonisation (E10.5-E13.5 in the mouse) the most
caudal cells are undifferentiated ENCC, and co-express Sox10, RET,
p75 and Phox2b (Young et al., 1998a, 1999, 2003). Migrating ENCC
also express EDNRB (Barlow et al., 2003; Gariepy et al., 1998) and
the transcriptional regulator Mash1 (Blaugrund et al., 1996; Lo et al.,
1991). Furthermore, chick sacral ENCC share gene expressionmarkers
including Sox10, EDNRB and RET (Delalande et al., 2008). Behind the
migratory front, ENCC are at different stages of differentiation, with
neurons appearing before glial cells (Young et al., 2003). Thus, differ-
entiation of vagal-derived ENCC into neurons takes place shortly after
invasion of the foregut and is accompanied by downregulation of
Sox10 and p75, maintenance of RET and Phox2b expression and
upregulation of pan-neuronal markers such as the ubiquitin hydrolase
PGP9.5, neuroﬁlament protein (NF), neuronal class III β-tubulin and
the RNA-binding proteins HuC and HuD (Sato and Heuckeroth,
2008; Young et al., 2002, 2003, 2005) (see Fig. 1). A subset of
Mash1+ neuronal differentiating cells also transiently expresses the
catecholaminergic marker tyrosine hydroxylase (TH) (Baetge and
Gershon, 1989; Blaugrund et al., 1996; Young et al., 1999). All these
neuronal-committed cells are considered to be progenitors at this
stage, since they lack neuron-subtype speciﬁc markers and are still
mitotically active (Baetge and Gershon, 1989; Sato and Heuckeroth,
2008; Young et al., 2003, 2005). Glial progenitors are ﬁrst identiﬁed
at E11.5 by expression of B-FABP and are locatedmainly in the foregut
andmidgut, a long way behind the migratory wavefront (Young et al.,
2003). These cells also maintain Sox10 and p75 expression and upre-
gulate S100 and GFAP only at E14.5 and E16.5, respectively (Rothman
et al., 1986; Young et al., 2003).
Molecular mechanisms controlling ENCC colonisation of the gut
ENS development is a complex and asynchronous process. As
ENCC migrate along the gut, they respond to proliferative signals
which increase their number at the migratory front enabling them
to invade and colonise further posterior regions as well as rapidly
populate growing gut colonised behind the wavefront. Concomitant-
ly, subsets of ENCC undergo lineage restriction to generate enteric
neurons and glial cells. Carefully controlled orchestration of these
processes is essential for the formation of a complete functional ENS
and involves many molecular mechanisms, some of which recently
have begun to be elucidated.
Cell numbers
The population size of pre-enteric NCC plays an important role in
determining the extent of gut colonisation. This has been demonstrat-
ed by reducing the initial number of vagal NCC in avian embryos in
vivo, which leads to incomplete colonisation of the gut (Burns et al.,
2000; Peters-van der Sanden et al., 1993; Yntema and Hammond,
1954). It is now clear that a minimal number of NCC is necessary for
the complete rostrocaudal colonisation of the gastrointestinal tract
(Barlow et al., 2008). The pool size of ENCC is also important for gov-
erning the speed of wavefront progression along the gut and the suc-
cessful colonisation of the entire organ. When cells at the leading
edge of the migratory front are isolated from the more rostral ENCC
population, the rate of migration is dramatically reduced (Young
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Progenitor cell
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Fig. 1. Summary of murine enteric nervous system development from neural crest cells (NCC) showing the migration of NCC along the gut, key cellular events, and the molecular
markers expressed by the various cell types.
Stage Cellular events Cell types Markers
E8.5 Delamination from vagal region of neural tube Vagal NCCs Sox10/p75
E9.5 Invasion of the embryonic foregut by vagal progenitor cells Pre-enteric NCCs Sox10/p75±RET/Phox2b
E10.5 Rostro-caudal migration of progenitor cells
Proliferation of progenitor cells
Start of neuronal differentiation
ENCCs (progenitor cells) Sox10/p75/RET/Phox2b; EDNRB; Mash1
Immature neurons RET/Phox2b/PGP9.5/HuC-D/TuJ1±Mash1/TH
E11.5 Rostro-caudal migration of progenitor cells
Proliferation of progenitor cells
Neuronal differentiation (appearance of ﬁrst neurotransmitters)
Start of glial differentiation
ENCCs (progenitor cells) Sox10/p75/RET/Phox2b; EDNRB; Mash1
Immature neurons RET/Phox2b/PGP9.5/HuC-D/TuJ1±Mash1/TH; ±NOS; ±Calb
Immature glial cells Sox10/p75/B-FABP
E13.5 Completion of rostro-caudal migration of vagal progenitor cells
Invasion of the embryonic hindgut and caudo-rostral migration
of sacral progenitor cells
Proliferation of progenitor cells
Neuronal differentiation
Glial differentiation
Sacral NCCs Sox10/p75±RET/Phox2b
ENCCs (progenitor cells) Sox10/p75/RET/Phox2b; EDNRB
Immature neurons RET/Phox2b/PGP9.5/HuC-D/TuJ1±NOS; ±Calb; ±VIP; ±NPY
Immature glial cells Sox10/p75/B-FABP
P0 (to adult) Proliferation of progenitor cells
Differentiation of mature neuronal phenotypes
Differentiation of mature glial phenotype/s
Gangliogenesis
Formation of functional neuronal circuits
(i.e. onset of coordinate intestinal motility)
ENCCs (progenitor cells) Sox10/p75±RET/Phox2b
Neurons RET/Phox2b/PGP9.5/HuC-D/TuJ1±NOS; ±Calb; ±VIP; ±NPY;
±SubP; ±CGRP; ±5HT; ±ChAT; ±Calret
Glial cells Sox10/p75/Phox2b/B-FABP/S100β/GFAP
.
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ments in embryonic avian gut in vitro have shown that unidirectional
colonisation of the gut is accomplished when cells at the wavefront
act as a proliferative source to generate enough motile ENCC toinvade previously unoccupied regions, while those behind the front
are essentially non proliferative and do not participate directly in
the invasion of unoccupied tissues (frontal expansion model)
(Simpson et al., 2007).
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Three major groups of molecules have been implicated to date in
the control of ENCC proliferation and survival during ENS develop-
ment, namely RET-GDNF, Endothelin-3(ET-3)-EDNRB and transcrip-
tion factors such as Sox10 and Phox2b. RET is a transmembrane
tyrosine kinase which acts as a receptor for the glial cell line-derived
neurotrophic factor (GDNF) family of ligands including GDNF, neur-
turin, artemin and persephin (Manié et al., 2001). Each ligand is able
to activate RET via binding to a preferred high-afﬁnity glycosylpho-
sphatidylinositol (GPI)-anchored co-receptor GFRα (GDNF family
receptor α-component), which is GFRα1 in the case of GDNF (Baloh
et al., 2000; Jing et al., 1996). RET is expressed in migratory ENCC
and, later, is maintained exclusively in the neuronal population
(Durbec et al., 1996; Pachnis et al., 1993; Young et al., 2003). GFRα1
expression is found both in ENCC and gut mesoderm (Chalazonitis
et al., 1998; Schiltz et al., 1999), whereas GDNF is speciﬁcally
expressed by the gut mesoderm (Natarajan et al., 2002; Young et al.,
2001). In mouse, mutation in the RET, GFRα1, or GDNF genes leads
to total intestinal aganglionosis, where ENCC fail to colonise the
gastrointestinal tract beyond the rostral stomach (Cacalano et al.,
1998; Enomoto et al., 1998; Moore et al., 1996; Pichel et al., 1996;
Sanchez et al., 1996; Schuchardt et al., 1994). In vitro and in vivo inves-
tigations on the effects of the targeted mutation of the gene encoding
RET (c-Ret) have revealed that the activation of the receptor by GDNF
is required at early stages of gut colonisation for survival of the
majority of ENCC. In the absence of RET, progenitors undergo exten-
sive apoptosis, which dramatically depletes the pool of cells able to
progress along the gut (Taraviras et al., 1999). In addition to its role
in cell survival, RET-GDNF signalling generates a strong proliferative
signal for ENCC in a time-dependent manner. In vitro studies have
shown that GDNF enhances cell proliferation and induces an increase
in the number of neuronal progenitors in early migratory ENCC
(Chalazonitis et al., 1998; Hearn et al., 1998; Heuckeroth et al., 1998;
Taraviras et al., 1999). In accordance with these studies, depletion of
GDNF in vivo, as reported in mice heterozygous for mutation in the
Gdnf gene (Gdnf+/−), leads to a reduced number of enteric neurons
along the intestine (hypoganglionosis) as a result of the diminished
proliferative capacity of progenitor ENCC (Gianino et al., 2003).
However, at later post-migratory stages, GDNF seems mainly to pro-
mote survival and neuronal differentiation (Chalazonitis et al., 1998;
Taraviras et al., 1999; Uesaka et al., 2007; Wang et al., 2010).
EDNRB is a G protein-coupled receptor for the small peptides
endothelin-1 (ET-1), ET-2 and ET-3 (Inoue et al., 1989). In the embry-
onic mouse gut, ET-3 is expressed by the gut mesenchyme, with its
highest levels in the caecum (Barlow et al., 2003; Leibl et al., 1999),
while EDNRB is expressed by both ENCC and non-neural crest gut tis-
sue (Barlow et al., 2003; Woodward et al., 2000; Wu et al., 1999).
Spontaneous or targeted mutations of the Ednrb or Et-3 locus lead
to identical phenotypes, characterised by the absence of enteric neu-
rons from the terminal region of the gut (colonic aganglionosis)
(Baynash et al., 1994; Hosoda et al., 1994; Kapur et al., 1995). In
vitro studies in mouse and avian showed that ET-3 inhibits or delays
neuronal differentiation of ENCC (Hearn et al., 1998; Wu et al.,
1999), with little or no effect on proliferation (Chalazonitis et al.,
1998; Heuckeroth et al., 1998; Kruger et al., 2003; Wu et al., 1999).
Further studies on clonogenic cultures of isolated ENS progenitor
cells (EPCs) have conﬁrmed that ET-3 is reversibly able to inhibit
the commitment of these cells towards neuronal and glial lineages,
maintaining them in an uncommitted state (Bondurand et al.,
2006). Therefore, it has been suggested that ET-3-EDNRB signalling
inhibits ENCC differentiation, instead promoting the maintenance of
a pool of undifferentiated and uncommitted progenitors that are
able to colonise all regions of the developing gut. In accordance
with this hypothesis, absence of ET-3 in vivo results in migratory
delay in colonisation of the gut (Barlow et al., 2003), associatedwith a reduced pool of proliferative progenitors and with premature
neuronal differentiation at the front of migration (Bondurand et al.,
2003). In addition, several interactions of ET3-EDNRB signalling in
cooperation with other signalling pathways have been reported to
control proliferation and/or differentiation of ENCC. For example,
ET-3 is able to synergistically increase the proliferative effect induced
by RET-GDNF signalling in vitro (Barlow et al., 2003), while in vivo,
mutations in Et-3 or EdnrB increase the severity of aganglionosis in
Sox10Dom/+ mice (Cantrell et al., 2004; Stanchina et al., 2006) and
in mice carrying only the monoisoformic c-Ret allele Ret51 (Barlow
et al., 2003).
Sox10 is a member of the SRY-box containing (Sox) family of tran-
scription factors (Bowles et al., 2000). Sox10 is expressed in NCC as
they emigrate from the neural tube and continues to be expressed
as they migrate towards their target tissues (Kuhlbrodt et al., 1998).
In post-migratory target tissues such as dorsal root ganglia (DRG)
and the ENS, Sox10 expression is present in undifferentiated multipo-
tent progenitors and, upon lineage segregation, is maintained only
by the glial cell lineage (Anderson et al., 2006a; Kuhlbrodt et al.,
1998; Paratore et al., 2001; Southard-Smith et al., 1998; Young et al.,
2003). In mouse, a spontaneous (dominant megacolon, Sox10Dom) and
a targeted (Sox10LacZ) mutation of Sox10 lead to colonic agangliono-
sis in heterozygosity and to total intestinal aganglionosis in homozy-
gosity in addition to several other defects in multiple neural crest
derivatives (Britsch et al., 2001; Herbarth et al., 1998; Lane and Liu,
1984; Southard-Smith et al., 1998). From in vivo studies, Sox10 is
thought to play a primary role in sustaining the survival of multipo-
tent undifferentiated NCC. In the absence of Sox10, a dramatic in-
crease in apoptotic death has been reported both in vagal NCC
prior to their entry into the rostral foregut (Kapur, 1999) and in
undifferentiated trunk NCC within the DRG (Paratore et al., 2001).
Premature death seems therefore to preclude the entrance of ENCC
into the gut, since investigations using progenitor markers failed to
ﬁnd any positive cells during the early stages of gut colonisation
(Kapur, 1999). A combination of in vivo and in vitro studies has also
implicated Sox10 in maintenance of ENCC in an undifferentiated
state. Paratore et al. (2002) reported that, in the case of Sox10 hap-
loinsufﬁciency, as seen in SoxLacZ/+ mice, the pool of ENCC expres-
sing progenitor markers such as Sox10 and p75 is reduced along
the gastrointestinal tract, with concomitant increase in cells expres-
sing neuronal precursor markers (Paratore et al., 2002). On the other
hand, Bondurand et al. (2006) showed that overexpression of Sox10
is able to reduce the number of neurons and glial cells differentiated
from ENS progenitors in vitro (Bondurand et al., 2006). Thus, these
ﬁndings demonstrate that Sox10 levels are indeed critical for main-
tenance of the ENS progenitor pool. Furthermore, Sox10 is part of a
molecular cascade that controls spatial and temporal commitment
and differentiation of the ENS by interacting with other signalling
pathways. In fact, genetic studies have shown that Sox10-binding
sites exist at the Ednrb enhancer and these are required for appropri-
ate spatiotemporal regulation of the gene in the developing ENS
(Zhu et al., 2004). In addition, other studies have implicated Sox10
in the regulation of c-Ret expression (Lang and Epstein, 2003; Lang
et al., 2000) and Phox2b (Elworthy et al., 2005; Kim et al., 2003).
Phox2b is a paired-homeodomain transcription factor which is
widely expressed in the developing autonomic nervous system
(Pattyn et al., 1997). Phox2b expression in vagal NCC occurs after
the expression of Sox10 and is maintained by all ENCC within the
embryonic mouse gut, including both neuronal and glial precursors
(Anderson et al., 2006a; Young et al., 1998a). Recently, a transgenic
line driving the cerulean ﬂuorescent protein (CFP) under control of
the Phox2b promoter has revealed differential levels of Phox2b
expression at the front of migrating ENCC as well as showing that
Phox2b expression persists both in mature enteric neurons and
glial cells (Corpening et al., 2008). Mice with targeted mutation of
the Phox2b locus (Phox2bLacZ) lack autonomic ganglia, including the
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the absence of Phox2b, vagal NCC enter the foregut but fail to express
markers such as RET, Mash1 and TH and they coalesce around the
esophageal–gastric junction before undergoing extensive apoptotic
death (Pattyn et al., 1999). These studies suggest a role for Phox2b
in control of ENCC survival by direct regulation of RET expression.Cell migration
Several processes involving responses to diffusible molecules,
extracellular matrix interactions, cell–cell interactions and intracellu-
lar reorganisation control motility and directionality of ENCC migrat-
ing through the gut mesenchyme. In vitro studies have shown that
GDNF acts as a chemoattractant for vagal NCC prior to their entry
into the gut and to ENCC within the gut. Thus the RET–GDNF signal-
ling pathway seems to play a key role in retaining NCC within the
gut mesenchyme, and also in inducing their rostro-caudal migration
(Natarajan et al., 2002; Young et al., 2001). In vivo, GDNF mRNA is
expressed by the gut mesenchyme in a time-dependent fashion,
with high levels initially in the foregut and later in the caecum,
which precede the colonisation of those regions by ENCC (Natarajan
et al., 2002). However, attempts to identify a GDNF gradient within
the pre-cecal gut have been unsuccessful (Anderson et al., 2007). In
fact, it is not known how ENCC are able to pass the caecum and pro-
ceed through the hindgut, since no other sources of GDNF have
been found in the most caudal regions of the gut. Experimental evi-
dence points to a GDNF-opposing role of ET-3, which is speciﬁcally
expressed in the caecum prior to the arrival of ENCC in this region
(Barlow et al., 2003). Addition of ET-3 in vitro enables ENCC present
in the proximal hindgut of ET-3 deﬁcient mice to fully colonise the
distal aganglionic regions (Wu et al., 1999) and speciﬁcally reduces
the chemoattractive effect of GDNF on ENCC migrating in a collagen
matrix from gut explants (Barlow et al., 2003; Kruger et al., 2003).
In addition, Druckenbrod and Epstein (2009) have recently shown,
by pharmacological inhibition of the EDNRB receptor in organ cul-
tures, that the migratory behaviour of ENCC is directly affected, and
results in retraction of cellular processes and loss of chain migration
(Druckenbrod and Epstein, 2009). Thus, ET-3 might be able to negate
GDNF attraction and enhance the migratory properties of ENCCs
within the caecal region, allowing the cells to progress further instead
of stalling.
As outlined above, sacral ENCC are delayed in their entry to the
gut, and once in the gut they migrate caudo-rostrally, unlike the
rostro-caudal migration of vagal ENCC. Some studies suggested that
sacral NCC colonisation of the gut might be inhibited by the temporal-
ly regulated expression of molecules in the hindgut, such as sema-
phorins. In avian embryos, Sema3A is transiently expressed in the
hindgut and it acts as a chemorepellent for axons of neurons present
in the nerve of Remark (Shepherd and Raper, 1999). When Sema3A
expression decreases during development, axons enter the hindgut
and sacral NCCs migrate along with them. Therefore it has been sug-
gested that Sema3A might account indirectly for the delayed entry
of the sacral-derived ENCC into the gut (Burns, 2005). In mouse,
Sema3A also is expressed in the most caudal regions of the gut and,
when absent, some sacral ENCC and extrinsic axons enter the distal
hindgut prematurely (Anderson et al., 2007). However, it is still not
clear if Sema3A acts directly on ENCC, and it is likely that other molec-
ular mechanisms are involved in the directed migration of sacral NCC
into the gut mesenchyme. A recent study in chick embryos from
Delalande et al. (2008) reported that sacral ENCC express mRNA tran-
script for RET almost 4-fold less than vagal ENCC. When RET is over-
expressed in sacral ENCC, increased number of cells enter the hindgut
earlier in development, thus suggesting differential control of a simi-
lar molecular mechanism underlies directed migration in vagal and
sacral ENCC (Delalande et al., 2008).ENCC migration involves the control of cell adhesion to extracellu-
lar matrix (ECM) components as well as between migrating cells
themselves. The intestinal ECM is a dynamic environment, with tem-
porally regulated expression of several molecules affecting the migra-
tory behaviour of ENCC during development. Thus, altered expression
of deﬁned ECM components or impairment in adhesive properties of
ENCC might lead to incomplete colonisation of the gastrointestinal
tract. Studies from Breau et al. (2009) have reported the existence
of a gradient of ECM components in the developing gut. For instance,
ﬁbronectin (FN) and tenascin C (TNC) are expressed by the mesen-
chyme of E11.5 mouse gut more abundantly in the caecum and hind-
gut compared to the midgut, whereas other components, such as
vitronectin, found in all pericellular spaces around epithelial and
mesenchymal cells, or laminin α1, laminin α5 and collagen V, found
mainly in the basal laminae, are expressed at similar levels in all re-
gions of the gut (Breau et al., 2009). The high levels of expression of
FN and TNC in the caecum and proximal hindgut coincide with the
timing of crossing of these regions by ENCC, which show opposing
migratory responses to them. In vitro tenascin C inhibits ENCC migra-
tion (Breau et al., 2009), which correlates with the temporary arrest
of migration observed when ENCC reach the base of the caecum
(Druckenbrod and Epstein, 2005). Conversely, FN promotes migra-
tion, cell adhesion and spreading through a mechanism involving
β1 integrins expressed on the surface of ENCC (Breau et al., 2006,
2009). Consistent with this, in vivo ablation of β1 integrin leads to a
delay in ENCC migration with an altered colonisation of the caecum
and hindgut, which ultimately results in colonic aganglionosis
(Breau et al., 2006, 2009). These ﬁndings suggest that expression of
β1 integrin is essential for ENCC to interact with ﬁbronectin and over-
come the TNC-mediated migratory inhibition during the invasion of
the caecum and proximal hindgut and suggest that alteration of adhe-
sive properties of ENCC might represent per se a molecular basis
for incomplete colonisation of the gut. In addition to these ﬁndings,
recent studies have shown how physiological or pathological changes
occurring during development in the structure of the intestinal
wall might account for defects in colonisation of distal segments of
the gut reported in several mutants. In fact, the intestinal mesen-
chyme undergoes dramatic changes during embryonic development
(Young, 2008), such as differentiation into speciﬁc cells types (i.e.
smooth muscle, mucosal and epithelial cells) and production of spe-
ciﬁc ECM components. In vitro recombination of E11.5 caecum grafts
into aganglionic hindgut explants of different developmental ages
demonstrated an age-dependent efﬁciency in colonisation of the
host gut, with the oldest (E16.5) explant the least colonised by
E11.5 donor ENCC (Hotta et al., 2010). Accordingly, other investiga-
tions showed decreased permissiveness to ENCC migration in the
hindgut between E13.5 and E14.5, a change possibly connected to
an increase in ECM deposition of laminin, a potent cue for differenti-
ation of enteric neurons (Druckenbrod and Epstein, 2009). It has also
been suggested that this change in the gut environment, which nor-
mally occurs during development, might create a physical obstacle
to a delayed wavefront of ENCC, as reported by the same authors
for Ednrb mutant ENCC (Druckenbrod and Epstein, 2009). On the
other hand, studies have shown that ET-3 mutations directly alter
the expression of laminin by the gut mesoderm and, along with the
cell-autonomous effects of the mutation, lead to terminal agangliono-
sis (Rothman et al., 1996; Tennyson et al., 1986; Wu et al., 1999).
Transient cell–cell interactions play a key role in migration of
NCC. Directional migration of cranial NCC has been shown to rely
on contact inhibition of locomotion (CIL), a cellular mechanism for
which, within a population of migrating cells, a cell becomes
polarised and initiates sustained directional migration away from
contact with another NCC (Carmona-Fontaine et al., 2008). In this
system, therefore, multiple transient cell interactions are necessary
for collective migration of the entire population of cells, whereas
loss of contact and cell isolation results in diminished chemotaxis
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2010). In the developing ENS, it is likely that a similar mechanism
acts on migrating ENCC. In vitro blocking of the cell adhesion mole-
cule L1 expressed on ENCC leads to partial disruption of the chains
of cells at the wavefront with increased numbers of isolated cells
and consequent incomplete colonisation of the distal gut, thus sug-
gesting that L1 dependent cell–cell contact is important for migra-
tion of ENCC (Anderson et al., 2006b). However, in vivo deletion
of L1 only results in a transient delay of ENCC, which does not lead
to aganglionosis (Anderson et al., 2006b), indicating that other
cell adhesion molecules might account for cell–cell interactions
within chains of migrating ENCC. It has been suggested that addition
of polysialic acid (PSA) to the neural cell adhesion molecule 1
(NCAM1) might affect the migration of ENCC into the hindgut in
E11.5 gut explants in vitro. Expression of PSA-NCAM1 is found in
both ENCC and the underlying muscle layer during foetal life, with
a consistent increase in maturing neurons and neurites as develop-
ment proceeds (Fu et al., 2006).
Cell migration requires polarisation and coordinated activation of
proteins, which ultimately control cytoskeleton remodelling. There
are some indirect data showing that inhibition of polarisation of
ENCC leads to delayed colonisation of the hindgut in organotypic cul-
tures of E11.5 guts (Vohra et al., 2007). In vitro, retinoic acid has
been shown to facilitate ENCC migration by reducing the levels of
the phosphatase and tensin homolog PTEN, whose function affects
the polarised and coordinated activity of proteins that regulate the
actin cytoskeleton (Fu et al., 2010). Candidate molecules suggested
to regulate the intracellular actin dynamics in response to chemotac-
tic signals such as GNDF include the Rho GTPases. Early biochemical
studies have shown that the phosphorylation of the serine residue
at codon 696 (S696) of RET is required for Rac1-GEF activation in
vitro (Fukuda et al., 2002) and that targeted mutation of S696 leads
to abnormal colonisation of the gut by ENCC in vivo (Asai et al.,
2006). More direct evidence of the involvement of Rho GTPases in
ENS development was reported by Stewart et al. (2007), who phar-
macologically inhibited the activity of Rac1/Cdc42 and Rho kinases,
Rock-I and Rock-II in intact gut explants (Stewart et al., 2007). The
authors found that inhibition of both Rac1/Cdc42 and Rho signalling
led to retarded migration of ENCC, without affecting cell proliferation
and differentiation. In addition, Rac1/Cdc42 also led to reduced pro-
trusions and cell–cell contacts in ENCC at the migratory wavefront.
These effects were shown to be possibly RET-dependent, since ENCC
in explants of guts from embryos that were heterozygous for RET
were more sensitive to the inhibitors (Stewart et al., 2007).
Development of enteric neurons
Neuronal subtype speciﬁcation
Enteric neurons are born and mature throughout foetal life and in
early postnatal stages. As early as E10–E10.5, neuronal progenitors
can be identiﬁed in the developing gut by expression of pan-
neuronal markers, along with maintenance or increase in RET expres-
sion (Baetge and Gershon, 1989; Young et al., 1999). Differentiation
into distinct neuronal subtypes is an asynchronous and heteroge-
neous process. Subtype-speciﬁc neuronal progenitors exit the cell
cycle during deﬁned developmental windows; however, immunore-
activity for the related neurotransmitters or subtype markers might
not appear until several days later. Moreover, as in other parts of
the nervous system, immature enteric neurons may express combina-
tions of neurotransmitters and neurotransmitter synthetic enzymes
that are not observed in mature neurons, while the full spectrum of
enteric chemical coding is only developed after birth. For example,
transient expression of the catecholamine synthetic enzyme tyrosine
hydroxylase (TH) is found in the majority of developing neurons be-
tween E10 and E12.5 (Baetge and Gershon, 1989; Young et al., 1999).These cells, which also co-express Mash1 and are still proliferative
(Baetge and Gershon, 1989; Blaugrund et al., 1996), have been sug-
gested to be neuronal progenitors of serotonergic neurons (Blaugrund
et al., 1996) and NOS (nitrergic) neurons (Young et al., 2002), but this
issue still remains controversial. Certainly, transiently expressing TH+
progenitors do not seem to generate the small population of cate-
cholaminergic neurons present in the adult mouse (Li et al., 2004).
The ﬁrst enteric neurons to express a neurotransmitter synthetic
enzyme present in mature enteric neurons are the NOS neurons
around E11.5–E12.5 (Baetge and Gershon, 1989; Hao et al., 2010;
Young et al., 2002). In addition, calbindin-positive (Hao et al.,
2010) and serotonergic (Rothman and Gershon, 1982) neurons are
also believed to develop around the same time. Analogously, cholin-
ergic neurons are thought to develop around E10 and E12, when
conversion of radioactive choline into acetylcholine (ACh) can be
recorded within the ENS (Rothman and Gershon, 1982). However,
only at E18.5 have the synthetic enzyme and the vesicular transport-
er for ACh been detected by immunolabeling (Vannucchi and
Faussone-Pellegrini, 1996). Furthermore, VIP and NYP immunoreac-
tivity are ﬁrst found around E13.5 (Branchek and Gershon, 1989;
Rothman et al., 1984), substance P at E14–E14.5 (Rothman et al.,
1984), CGRP at E17 (Branchek and Gershon, 1989), while calretinin
has been ﬁrst reported only at P0 (Young et al., 1998b).
Two major signalling pathways have been shown to regulate the
relative abundance of neuronal classes within the developing ENS
by controlling proliferation of neuronal progenitors: GDNF and BMP.
A recent study has shown that temporal control of GDNF expression
regulates the proliferation of speciﬁc precursors and thus the abun-
dance of speciﬁc subclasses of postmitotic enteric neurons (Wang
et al., 2010). When GDNF is over-expressed at late stages of develop-
ment under control of the GFAP promoter (from ~E17 onwards), the
number of neurons expressing NADPH-diaphorase, a marker for NOS
activity, is increased, whereas neurons expressing ChAT/Substance P
remain unaffected. Since NOS progenitors proliferate up to P1, in con-
trast to choline acetyltransferases (ChAT) progenitors that undergo
cell cycle exit by E15, this result suggests a selective mitogenic effect
of GDNF based on the stage that enteric neuronal precursors exit the
cell cycle (Wang et al., 2010). Partially consistent with these ﬁndings,
in vivo GDNF haploinsufﬁciency leads to a reduction in the number of
myenteric neurons (Gianino et al., 2003), with some studies indicat-
ing concomitant reduction in the proportion of NOS and ChAT myen-
teric neurons in the small intestine (Wang et al., 2010), and others
suggesting unaffected proportion of NOS myenteric neurons in the
colon (Roberts et al., 2008). Bone morphogenetic proteins (BMPs)
play a role in enteric neuronal development by possibly acting on sev-
eral molecular processes similar to those controlled by GDNF. In vitro
concentration-dependent activity of BMP-2 and BMP-4 increases
neuronal differentiation and affects neuronal survival of puriﬁed
enteric progenitors (Chalazonitis et al., 2004). In vivo, overexpression
of the BMP inhibitor noggin under control of the neuron speciﬁc eno-
lase (NSE) is associated with a signiﬁcant increase in the number of
enteric neurons in both enteric plexi with different effects on speciﬁc
neuronal subtypes. Noggin-mediated BMP antagonism leads to an
increase in number of neurons derived from precursors that exit the
cell cycle early in neurogenesis (serotonin, calretinin and calbindin
neurons), whereas those that exit the cell cycle late (CGRP, GABA,
TH, DAT neurons) were decreased, and NOS neurons remained unaf-
fected (Chalazonitis et al., 2004, 2008). Thus, BMP signalling might
contribute to enteric neuronal phenotypic diversity by promoting
cell cycle exit of neuronal precursors at appropriate developmental
time points.
Neuronal commitment of ENCC progenitors is a process that is
strictly connected to maintenance of their undifferentiated state.
Thus, the function of transcription factors such as Sox10, which
have been found to inhibit neuronal differentiation, must be down
regulated during neuronal speciﬁcation (Bondurand et al., 2006).
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promotes several aspects of neurogenesis in the CNS, suppresses
Sox10 expression in some of the enteric progenitors that give rise to
neurons (Okamura and Saga, 2008). Another bHLH transcription
factor, Hand2, has been found to modulate neuronal development
by promoting terminal differentiation of enteric neuronal progeni-
tors (D'Autreaux et al., 2007; Hendershot et al., 2007). In fact, con-
ditional ablation of Hand2 affects neuronal differentiation of ENCC
in vitro and in vivo and in the absence of subtype-speciﬁc markers
such as NOS and VIP in the gut of embryonic mice in vivo (D'Autreaux
et al., 2007; Hendershot et al., 2007).
Additionally, some studies have also implicated ET-3 in late events
of neuronal differentiation. In fact, in ET3 null mice, an increase in the
proportion of NOS+ myenteric neurons has been reported in the re-
gion rostral to the aganglionic colon (Roberts et al., 2008) and in
the small intestine (Sandgren et al., 2002), thus suggesting a subtle
effect of this mutation on the phenotype of enteric neurons.
Genetic control of neuronal subtype speciﬁcation is still a key issue
in ENS development. To date, few mutations result in loss of speciﬁc
neuronal subtypes, suggesting that neuronal differentiation might
be the result of the combined activity of one or more genetic factors.
Mash1 is the only transcription factor that has been unequivocally as-
sociated with the development of a deﬁned neuronal population such
as the serotonergic subtype. Targeted ablation of Mash1 leads to lack
of neurons in the oesophagus in addition to a failure to develop TH+
progenitors and 5-HT neurons along the entire gastrointestinal tract
(Blaugrund et al., 1996). Similarly, mice lacking the tyrosine kinase
receptor C (TkrC) or its ligand neurotrophin-3 (NT-3) show reduction
in myenteric neuron number and have a dramatic decrease in CGRP
positive submucosal neurons (Chalazonitis et al., 2001).Morphological development of enteric neurons
Most classes of enteric neurons possess a characteristic morpholo-
gy with the presence of one or more axons, different shape of den-
drites and several degrees of branching, as originally described by
Dogiel in the late 1800s. Development of speciﬁc neuronal morphol-
ogies involves growth of neurites and speciﬁcation of axons and den-
drites. From in vivo studies involving the use of the lipophilic dye, DiI,
to retrogradely label neuronal projection and cell bodies, Young et al.
(2002) found that the majority of neurons present in E11.5–E16.5
mouse gut had one single long process and multiple short neurites,
suggesting the establishment of neuronal polarity at early stages of
ENS development (Young et al., 2002). Few studies have addressed
the molecular mechanisms underlying neuritogenesis and determi-
nation of neuronal polarity in the developing ENS. Evidence emerging
from the work of Vohra et al. (2007) demonstrates a role for protein
kinase C zeta (PKCζ) and glycogen synthase kinase 3β (GSK3β) in
axon speciﬁcation of enteric neurons. In culture, the majority of neu-
rons developing from immunoselected rat ENCC produce a single
axon. PKCζ and GSK3β transiently localise at the tip of growing
axons and pharmacological inhibition of their activity resulted in an
increase in both the number of multi-axonal neurons and the number
of neurons without any axons, indicating that PKCζ and GSK3β are
able to inﬂuence neuronal polarity and are likely to inﬂuence the
number of axons in enteric neurons. Furthermore, the authors also
implicated PKCζ and GSK3β activity in neurite growth, via a mecha-
nism that most likely involves recruitment of SMURF1 protein,
which, in turn, promotes RhoA degradation (Vohra et al., 2007). Con-
versely, retinoic acid (RA) reduces neurite length in cultured enteric
neurons by decreasing the levels of expression of smurf1 and, conse-
quently, increasing the abundance of RhoA protein, especially at the
tip of neurites (Sato and Heuckeroth, 2008). Nevertheless, there is
currently no information on the relevance of genetic programmes
and environmental cues on the morphological maturation of entericneurons and on the expression of intracellular components and regu-
lators of cytoskeleton dynamics during development.
Axon guidance
Mature enteric neurons differ in their axon projection patterns
and cell targets. Some classes of neurons project orally, others project
anally, circumferentially and locally. Very little is known about the
mechanisms controlling directional navigation of enteric axons to
their correct targets. DiI tracing of neuronal projections in E11.5–
E12.5 mouse gut revealed that many of the ﬁrst differentiating neu-
rons have a long longitudinal process which projects anally, whereas
oral projecting neurons appear to develop only at later stages (Young
et al., 2002). By immunoﬂuorescence analysis, it is possible to identify
many of the caudally projecting neurons as TH and NOS positive
(at E11.5 and E12.5 respectively), with cell bodies located between
tens to hundreds of microns behind the wavefront and their process-
es often in contact with migrating ENCC at the leading edge (Breau
et al., 2006; Young et al., 1999, 2002). Furthermore, the longitudinal
processes of individual neurons form prominent bundles of ﬁbres
shortly after each gut region is colonised by ENCC (Hao and Young,
2009; Young et al., 2002). Thus, there must be some neural guidance
cues allowing growing axons to sense the polarity of the gut and also
somemolecular mechanisms that mediate interaction of axons for the
formation of longitudinal ﬁbres. In co-culture experiments in which
vagal ENCC were forced to migrate caudo-rostrally, most of the neu-
rons projected rostrally, suggesting that migration and axon guidance
are associated at least during early stages of colonisation of the gut
(Young et al., 2002). However, the molecular mechanism linking neu-
ronal processes to undifferentiated ENCC is not yet clear; moreover,
this hypothesis cannot explain the onset of oral/circumferential pro-
jecting neurons or the patterning of projections after ENCC migration
is concluded.
To date, there have been no defects in enteric axon targeting
described in mice lacking any of the major neural guidancemolecules.
Nevertheless, it has been reported that mice, in which neurturin
(NRTN, one of the members of the GDNF family of ligands) or
GFRα2 (NRT high afﬁnity co-receptor) have been genetically ablated,
have a drastic reduction of cholinergic ﬁbres projecting to the circular
muscle, whereas there are no changes in NOS-containing nerve ﬁbres
(Heuckeroth et al., 1999; Rossi et al., 1999). Since density of neurons
is unaffected by the mutations (Gianino et al., 2003), it has been sug-
gested that NRTN produced by the circular muscle layer acts as a
chemoattractant or a trophic cue for axons of a sub-population of
myenteric neurons. Recently, transgenic mice overexpressing GDNF
have shown an increase in NADPH-diaphorase ﬁbres surrounding
and connecting ganglia, without similar changes in TH or ChAT positive
ﬁbres. This accumulation matched the distribution of GFAP-expressing
glial cells, thus suggesting that the spatial expression of GDNF can
attract speciﬁc subsets of neuronal processes (Wang et al., 2010).
Future directions
It is evident from the above review of the literature that a consid-
erable body of evidence exists concerning the mechanisms that regu-
late the proliferation, survival, migration and differentiation of the
NCC-derived precursors that form the ENS. Although numerous ques-
tions remain to be addressed, many of the major genes and signalling
pathways controlling these processed have been identiﬁed in labora-
tory animals and their involvement in ENS development in humans
has been largely conﬁrmed. However, our knowledge of the develop-
ment of gut motility is more rudimentary (Burns et al., 2009) and our
understanding of the aetiopathology of enteric neuropathies is also
lacking (possibly with the exception of Hirschsprung's disease).
Thus, unravelling the links between ENS development, ENS physiolo-
gy, and ENS disease is likely to be a priority for the ﬁeld for the next
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ity disorders.Development of gut motility
In the developing human gut, ENCC colonisation, differentiation of
the muscle layers and the development of interstitial cells of Cajal
(ICC) occur in a similar sequence to that described in laboratory ani-
mals. ENCCs complete their rostro-caudal migration between weeks
4 and 7 of development (Wallace and Burns, 2005), and by week
24 a full complement of enteric neurotransmitters is present (Rauch
et al., 2006; Timmermans et al., 1994; Walters et al., 1993). However,
the development of gut motility does not occur until late gestation
and after birth (Berseth, 1996; Burns et al., 2009) indicating that
there is a signiﬁcant time lag between the appearance of neurons
within the gut, and the establishment of neural control of gut motil-
ity. Since little is known about the development of functional neuro-
nal subtypes, and even less about how circuits underlying motility
reﬂexes are formed during this time window, the relationship
between ENS development and the neurally-mediated control of
gut motility (“ENS developmental physiology”) will be a key area
of research in the coming years.Better understanding of congenital diseases affecting the ENS
Current evidence indicates that enteric neuropathies arise from
loss, degeneration, and/or functional impairment of enteric neurons
resulting from congenital developmental defects of the ENS, the
action of known agents (i.e. toxic, infectious), or secondary to patho-
logical conditions such as chronic inﬂammation, diabetic neuropathy,
and Parkinson's disease. Nevertheless, for many of the primary enter-
ic neuropathies, the aetiology is still unclear andmay involve multiple
causes (Di Nardo et al., 2008). The best known enteric neuropathy is
Hirschsprung's disease (HSCR), a congenital condition associated
with a failure of ENCC to colonise the entire length of the gut resulting
in the absence of myenteric and submucosal neurons in the variable
lengths of the colon and rectum. Although the genetics and aetiology
of HSCR are now relatively well understood and are reviewed exten-
sively elsewhere (Amiel et al., 2008; Kenny et al., 2010), other com-
mon intestinal disorders have also shown some genetic inheritance,
but the lack of deﬁned neuropathological features and few animal
models in which speciﬁc motility disturbances can be investigated
(Margolis et al., 2011), have hindered research of their aetiology. Cur-
rent and future work, in which patients with speciﬁc motility defects
are grouped together and genotype/phenotype can be established,
should help to identify the mechanisms underlying such enteric
neuropathies.Cell therapies for the treatment of motility disorders
Although gut motility disorders represent a signiﬁcant challenge
in clinical management with little in the way of deﬁnitive cures, a
number of recent studies (Lindley et al., 2008; Metzger et al., 2009;
Tsai et al., 2010) have suggested that stem cells (mainly sourced
from the gut) have the potential to replace/restore missing or defec-
tive ENS cells in aganglionic gut, thus offering hope for the develop-
ment of novel therapies for neuropathies such as HSCR. Although
the work in animal models has been exciting and encouraging, the
next challenges will be to isolate and characterise ENS stem cells
from the human gut, demonstrate that transplanted ENS stem cells
have the capacity to inﬂuence/restore gut motility, and progress to
“ﬁrst in man” studies whereby cell delivery methods, safety and efﬁ-
cacy can be assessed.References
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